Metabolic characteristics and diagnostic biomarkers of malnutrition in maintenance hemodialysis patients based on WGCNA analysis
4 affiliations
- 1Department of Emergency, General Hospital of Ningxia Medical University, Yinchuan, China
- 2Department of Nephrology, People’s Hospital of Ningxia Hui Autonomous Region, Yinchuan, China
- 3First Clinical Medical College, Ningxia Medical University, Yinchuan, China
- 4Department of Medical Sciences Research Institute, General Hospital of Ningxia Medical University, Yinchuan, China
Abstract
Objective: Malnutrition is a common and serious complication in maintenance hemodialysis (MHD) patients, significantly impacting their prognosis. However, the metabolic characteristics and diagnostic biomarkers of the nutritional status of MHD patients remain inadequately explored.
Methods: We compared the clinical baseline characteristics between 100 MHD patients and 60 healthy controls. According to the Modified Quantitative Subjective Global Assessment (MQSGA) scores combined with clinical biochemical indicators, the MHD patients were divided into three groups: the well nourished group (Group A), the mild to moderate malnutrition group (Group B), and the severe malnutrition group (Group C). We then analyzed the differences in MQSGA scores and clinical characteristics among these three groups. Untargeted plasma metabolomics profiles were analyzed to identify differential metabolites and dysregulated metabolic pathways. Additionally, weighted gene co-expression network analysis (WGCNA) was employed in this study to screen key metabolic modules and potential biomarkers associated with malnutrition in MHD patients. Finally, the sensitivity and specificity of the core metabolites were evaluated using receiver operating characteristic (ROC) curves, and the reliability of candidate metabolite results was validated by colorimetric methods.
Results: Clinical data results showed that compared with normal population, the MHD patient group exhibited decreased expression of nutritional indicators (BMI, Alb, PA, Hb) and bone metabolism-related indicators (Ca, VitD, Klotho). Furthermore, as the severity of malnutrition increased, the levels of these indicators gradually decreased. Conversely, the levels of Scr, BUN, P, CRP, iPTH, and FGF-23 gradually increased. Metabolomics results identified multiple differential metabolites among the three groups, and KEGG analysis revealed enrichment in steroid biosynthesis and the arginine-proline pathway. In addition, revealed significant alterations in both steroid biosynthesis and arginine-proline metabolism modules, characterized by markedly reduced levels of 25(OH)D3, Calcidiol, and Pregnanediol. Conversely, the concentrations of L-glutamate and trans-4-hydroxy-L-proline were significantly elevated (P < 0.05). Moreover, the results of ROC curve analysis combined with validation tests indicate that the above five metabolites may have good diagnostic performance for MHD patients with malnutrition (P < 0.05).
Conclusion: Our findings highlight the metabolic derangements underlying malnutrition in MHD patients and propose novel biomarkers for early diagnosis. These insights may facilitate targeted interventions to improve clinical outcomes.
Related
- Development of a nomogram for identifying prevalent medication discrepancy in maintenance hemodialysis patients: a multicenter cross-sectional study
- Prevalence and factors associated with pulmonary hypertension in patients undergoing maintenance hemodialysis: a systematic review and meta-analysis
- Construction and validation of an identification model for frailty in maintenance hemodialysis patients using multiple machine learning algorithms: a cross-sectional study of retrospectively collected data
- Physiological discordance between clinical examination, bioimpedance spectroscopy, and lung ultrasound in maintenance hemodialysis patients without heart failure
- Effects of Dialysate Calcium Concentration on Bone, Mineral Metabolism, and Vascular Outcomes in Maintenance Hemodialysis: A Systematic Review and Meta-Analysis
BibTeX
@article{shi2026metabolic,
title = {{Metabolic characteristics and diagnostic biomarkers of malnutrition in maintenance hemodialysis patients based on WGCNA analysis}},
author = {Bin Shi and Xuyan Wang and Jingya Zhang and Liang Du and Hongyan Luo and Haixin Xu and Jing Xie and Jia Cao and Li Cao},
journal = {Frontiers in Physiology},
year = {2026},
month = oct,
doi = {10.3389/fphys.2026.1822660},
url = {https://doi.org/10.3389/fphys.2026.1822660},
note = {CC BY 4.0},
}
RIS
TY - JOUR
TI - Metabolic characteristics and diagnostic biomarkers of malnutrition in maintenance hemodialysis patients based on WGCNA analysis
AU - Bin Shi
AU - Xuyan Wang
AU - Jingya Zhang
AU - Liang Du
AU - Hongyan Luo
AU - Haixin Xu
AU - Jing Xie
AU - Jia Cao
AU - Li Cao
PY - 2026
DA - 2026/10/13
JO - Frontiers in Physiology
DO - 10.3389/fphys.2026.1822660
UR - https://doi.org/10.3389/fphys.2026.1822660
AB - Objective: Malnutrition is a common and serious complication in maintenance hemodialysis (MHD) patients, significantly impacting their prognosis. However, the metabolic characteristics and diagnostic biomarkers of the nutritional status of MHD patients remain inadequately explored. Methods: We compared the clinical baseline characteristics between 100 MHD patients and 60 healthy controls. According to the Modified Quantitative Subjective Global Assessment (MQSGA) scores combined with clinical biochemical indicators, the MHD patients were divided into three groups: the well nourished group (Group A), the mild to moderate malnutrition group (Group B), and the severe malnutrition group (Group C). We then analyzed the differences in MQSGA scores and clinical characteristics among these three groups. Untargeted plasma metabolomics profiles were analyzed to identify differential metabolites and dysregulated metabolic pathways. Additionally, weighted gene co-expression network analysis (WGCNA) was employed in this study to screen key metabolic modules and potential biomarkers associated with malnutrition in MHD patients. Finally, the sensitivity and specificity of the core metabolites were evaluated using receiver operating characteristic (ROC) curves, and the reliability of candidate metabolite results was validated by colorimetric methods. Results: Clinical data results showed that compared with normal population, the MHD patient group exhibited decreased expression of nutritional indicators (BMI, Alb, PA, Hb) and bone metabolism-related indicators (Ca, VitD, Klotho). Furthermore, as the severity of malnutrition increased, the levels of these indicators gradually decreased. Conversely, the levels of Scr, BUN, P, CRP, iPTH, and FGF-23 gradually increased. Metabolomics results identified multiple differential metabolites among the three groups, and KEGG analysis revealed enrichment in steroid biosynthesis and the arginine-proline pathway. In addition, revealed significant alterations in both steroid biosynthesis and arginine-proline metabolism modules, characterized by markedly reduced levels of 25(OH)D3, Calcidiol, and Pregnanediol. Conversely, the concentrations of L-glutamate and trans-4-hydroxy-L-proline were significantly elevated (P < 0.05). Moreover, the results of ROC curve analysis combined with validation tests indicate that the above five metabolites may have good diagnostic performance for MHD patients with malnutrition (P < 0.05). Conclusion: Our findings highlight the metabolic derangements underlying malnutrition in MHD patients and propose novel biomarkers for early diagnosis. These insights may facilitate targeted interventions to improve clinical outcomes.
SN - 1664-042X
ER -